Department of Urology, National Academy of Medical Sciences, Bir Hospital, Mahaboudha, Kathmandu, Nepal.
J Nepal Health Res Counc. 2023 Mar 10;20(3):768-773. doi: 10.33314/jnhrc.v20i3.4613.
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral length could predict need of surgery in patients with benign prostatic hyperplasia.
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated with International Prostate Severity Score, serum Prostate Specific Antigen, Transrectal Ultrasound was done to measure prostatic urethral length, prostate volume, Intravesical prostatic protusion and Post-void Residual Urine. Patients not responding to medical treatment and complications secondary to benign prostatic hyperplasia underwent surgery. Logistic regression analysis was performed to identify risk factors associated with surgery.
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volume, serum prostate specific antigen, and prostatic urethral length were significantly higher in the surgical group. The mean prostatic urethral length in the surgical group was 39.47 + 10.2 mm and in the nonsurgical group was 26.20 + 6.72 mm (p <0.0001). According to the ROC curve-based prediction of surgery, the area under the curve for PUL was 0.866 and the best cutoff value was 31.5mm (81% sensitivity and 84.3% specificity).
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract symptoms; prostatic urethral length.
良性前列腺增生与结构和形态变化有关,包括前列腺尿道长度的延长。我们的研究目的是评估前列腺尿道长度是否可以预测良性前列腺增生患者的手术需求。
这是一项为期 12 个月的前瞻性观察研究。所有因良性前列腺增生而出现下尿路症状的患者均接受国际前列腺症状评分、血清前列腺特异性抗原、经直肠超声检查,以测量前列腺尿道长度、前列腺体积、膀胱内前列腺突出和残余尿量。对药物治疗无反应且良性前列腺增生引起并发症的患者进行手术。采用逻辑回归分析确定与手术相关的危险因素。
共有 153 例患者纳入研究。在研究期间,83 例(54.2%)患者接受了手术。手术组前列腺体积、膀胱内前列腺突出、残余尿量、血清前列腺特异性抗原和前列腺尿道长度均显著升高。手术组前列腺尿道长度的平均值为 39.47 + 10.2mm,非手术组为 26.20 + 6.72mm(p <0.0001)。根据基于 ROC 曲线的手术预测,PUL 的曲线下面积为 0.866,最佳截断值为 31.5mm(81%的敏感性和 84.3%的特异性)。
前列腺尿道长度较长的 BPH 患者可能需要手术治疗。TRUS 测量的 PUL 可能是 BPH 手术需求的预测因素。关键词:良性前列腺增生;下尿路症状;前列腺尿道长度。